Back

Pathophysiological consequences of the EAST-AFNET4 trial: AF is not an innocent bystander

Cardiovascular Research

27 November 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Andreas Goette
Andreas Goette

Author

Saint Vincenz Hospital Paderborn Paderborn , Germany

You may be interested in
thumbnail
Congress Session
Clinical aspects in atrial fibrillation care
31 March 2025
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Incidence of left atrial thrombi in patients with atrial fibrillation and low thromboembolic risk: do we always need transesophageal echocardiography before rhythm control therapy?
13 April 2026
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources